Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Molecular Cancer Research : MCR|April 17, 2021
NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR VariantsKatherine L Morel, Anis A Hamid, John G Clohessy, et al.Genome Biology|January 22, 2021
Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAsYang Zhang, Tuan M Nguyen, Xiao-Ou Zhang, et al.Oncotarget|March 25, 2014
Role of aberrant PI3K pathway activation in gallbladder tumorigenesisAndrea Lunardi, Kaitlyn A Webster, Antonella Papa, et al.Blood|August 12, 2009
The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse modelKe Cheng, Paolo Sportoletti, Keisuke Ito, et al.Blood|January 24, 2008
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mousePaolo Sportoletti, Silvia Grisendi, Samia M Majid, et al.Cancer Research|March 30, 2011
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesisCaterina Nardella, Andrea Lunardi, Giuseppe Fedele, et al.Nature|December 27, 2016
mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptideAkinobu Matsumoto, Alessandra Pasut, Masaki Matsumoto, et al.Plos One|September 10, 2013
The RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cellsSharmila Fagoonee, Claudia Bearzi, Ferdinando Di Cunto, et al.Nature Communications|January 17, 2018
Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanismMing Chen, Lixin Wan, Jiangwen Zhang, et al.Theranostics|September 20, 2019
CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung CancerAzhar Ali, Elena Levantini, Chee Wai Fhu, et al.Pageof 6